Regulation of polo-like kinase 1 by DNA damage in mitosis: Inhibition of mitotic PLK-1 by protein phosphatase 2A

Biochemistry, Genetics and Molecular Biology

• Polo-Like Kinase 100%
• DNA Damage 45%
• Mitosis 36%
• Kinase 27%
• G2 Phase 27%
• Ataxia Telangiectasia Mutated 27%
• Protein Phosphatase 18%
• DNA Damage Response 18%
• Cell Cycle 9%
• Phosphatase 9%
• Mitosis Inhibition 9%
• Cell Cycle Checkpoint 9%
• Cell Cycle Progression 9%
• Dephosphorylation 9%
• Lysozyme 9%
• DNA Damage Checkpoint 9%
• Doxorubicin 9%
• Experiment 9%
• Regulatory Mechanism 9%
• Small Interfering RNA 9%
• DNA Synthesis Inhibition 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Polo Like Kinase 1 100%
• DNA 72%
• Mitosis 36%
• Cell Cycle 27%
• Ataxia Telangiectasia 27%
• ATR Protein 18%
• Enzyme 9%
• Phosphotransferase 9%
• Irradiation 9%
• Doxorubicin 9%
• Small Interfering RNA 9%
• Phosphoprotein Phosphatase 9%
• Phosphatase 9%
• Phosphoprotein Phosphatase 2A 9%